<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>作为您在 Google 上的首选新闻来源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>Sanuwave Health, Inc.(SNWV) 是一家医疗设备公司，周五表示预计其第四季度收入将在 1330 万美元至 1340 万美元之间，比去年同期增长 29% 至 30%。</p>
<p>Sanuwave Health 的首席执行官 Morgan Frank 表示：“正如我们在发布第三季度财报时讨论的那样，2025 年下半年是伤口护理领域剧烈转型的时期，皮肤替代品和同种异体移植物的报销率降低深刻重塑了我们的市场。这种重组时期总是充满机会。”</p>
<p>如有意见和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

SNWV

<p>SANUWAVE Health, Inc. (SNWV) 宣布预计其第四季度收入将在 1330 万美元到 1340 万美元之间，较去年增长 29% 至 30%。首席执行官 Morgan Frank 强调，由于报销率的变化，伤口护理市场正在进行转型，他将其视为增长的机会</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>作为您在 Google 上的首选新闻来源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>Sanuwave Health, Inc.(SNWV), a medical devices company, said on Friday that it expects its fourth-quarter revenue to be in the range of $13.3 million to $13.4 million, an increase of 29% to 30% from the same period last year.</p>
<div class="lb-trans"><p>Sanuwave Health, Inc.(SNWV) 是一家医疗设备公司，周五表示预计其第四季度收入将在 1330 万美元至 1340 万美元之间，比去年同期增长 29% 至 30%。</p>
</div><p>Morgan Frank, CEO of Sanuwave Health, said: &#34;As we discussed when releasing Q3, the second half of 2025 was a time of intense transition in the wound care space as reductions to reimbursement rates for skin-substitutes and allografts profoundly reshaped our market. Periods of such rearrangement are always times of opportunity.&#34;</p>
<div class="lb-trans"><p>Sanuwave Health 的首席执行官 Morgan Frank 表示：“正如我们在发布第三季度财报时讨论的那样，2025 年下半年是伤口护理领域剧烈转型的时期，皮肤替代品和同种异体移植物的报销率降低深刻重塑了我们的市场。这种重组时期总是充满机会。”</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意见和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

SANUWAVE Health 第四季度初步收入上升